Aviwell's AI Microbiome Platform Secures €11 Million Investment
Toulouse, Friday 23 January 2026
Toulouse-based Aviwell received €11 million in Series A funding on 22 January 2026. The funding will scale its AI platform for animal nutrition, potentially reducing reliance on antibiotics.
Investment Details and Lead Investors
The Series A investment round was spearheaded by the Blue Revolution Fund (BRF), with additional backing from Blast.Club and SWEN Capital Partners [3]. Existing investors Elaia and MFS Investment Management also participated in the round, demonstrating continued confidence in Aviwell’s vision [3]. This financial boost aims to accelerate the translation of microbiome science into nature-based solutions for animal nutrition, enhancing Aviwell’s AI-driven Aneto™ platform and expanding its commercial reach [2].
Aneto™ Platform and its Capabilities
Aviwell’s proprietary Aneto™ platform is central to its innovative approach. It leverages decades of research by Prof. Remy BURCELIN into bacterial ecologies and their effects on animal health and growth [1][2]. Aneto™ employs AI and machine learning to analyse microbiota, pinpointing bacterial communities that enhance animal performance, immunity, and overall robustness [1]. By identifying molecular mechanisms for selecting native bacterial communities, Aneto™ facilitates the development of tailored bacterial ecologies [2].
Strategic Focus and Market Impact
With the newly acquired capital, Aviwell intends to advance microbial ecologies specifically for poultry and aquaculture [1]. The company aims to broaden the services offered through its Aneto™ platform, strengthen its discovery capabilities, and deepen its commercial engagement [1]. Aviwell’s President and CEO, Mouli RAMANI, stated that Aneto™ can translate microbiome complexity into practical solutions, helping livestock and aquaculture producers improve productivity while reducing their environmental footprint [1].
Investor Perspectives
Georg BAUNACH, Managing Partner at BRF, expressed his admiration for Aviwell’s scientific depth and technological precision, viewing Aneto™ as a new generation of microbiome innovation that captures the complexity of biological systems [1][2][3]. Anthony BOURBON, founder of Blast.Club, highlighted that their investment in Aviwell was driven by the company’s revolutionary approach to the agri-food industry, using AI and life sciences to naturally boost animal growth without relying on hormones or antibiotics, by working on the microbiota [2][3]. These endorsements underscore the potential impact of Aviwell’s technology on sustainable animal nutrition [2].